Use this URL to cite or link to this record in EThOS:
Title: Development of plasmids that can displace antibiotic resistance plasmids from bacteria in the human and animal gastrointestinal tract
Author: Lazdins, Alessandro
ISNI:       0000 0004 7226 9738
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Antibiotic resistance is one of the greatest scientific and medical challenges of the 21st century. However, our arsenal to combat this surge is limited to a small number of antimicrobial drugs. Plasmids are major contributors to the problem, yet specifically targeting them to reduce the burden of resistant infections has not been fully exploited. It is possible to repress plasmid’s replication and eliminate them from a population by harnessing their innate replication and maintenance functions. This concept has been applied in this study to construct conjugative broad-host range plasmids aimed at curing either IncF or IncK plasmids based on IncPα RK2 and pUB307 backbones. pUB307- based pCURE gave a stronger curing phenotype as tested by a novel simple curing experiment and long-term invasion assays. The curing potentiation was investigated and found to be due to the absence of iteron 10 in oriV and a resulting higher copy number. The clinical potential of the technology was demonstrated by successfully curing a novel resistance plasmid, pEK499 and by in vivo mice experiments where pCURE conjugated into and cured target plasmids from E. coli established within the gastrointestinal tract. With further work to ensure long-term curing and biosafety, pCURE could improve the treatment options for multi-drug resistant infections.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QH301 Biology